• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙戊酸与伏立诺他相比对人结肠癌SW48细胞体外生长抑制和凋亡诱导的影响。

Effect of valproic acid in comparison with vorinostat on cell growth inhibition and apoptosis induction in the human colon cancer SW48 cells in vitro.

作者信息

Sanaei M, Kavoosi F, Mansoori O

机构信息

Research Center for Non-communicable Diseases, Jahrom University of Medical Sciences, Jahrom 74148-46199, Iran.

Student Research Committee, Jahrom University of Medical Sciences, Jahrom 74148-46199, Iran.

出版信息

Exp Oncol. 2018 Jun;40(2):95-100.

PMID:29949538
Abstract

AIM

Acetylation levels of histones are the result of the balance between histone acetyltransfrases and histone deacetylases activities, which plays an important role in chromatin remodeling and regulation of gene expression. Histone deacetylases inhibitors such as valproic acid, vorinostat have attracted interest because of their ability to induce differentiation and apoptosis of cancer cells. The current study was designed to assess the effect of valproic acid in comparison to and in combination with vorinostat on cell growth inhibition and apoptosis induction in the human colon cancer SW48 cells.

MATERIALS AND METHODS

The colon cancer SW48 cells were seeded and treated with various doses of valproic acid and vorinostat and MTT assay and flow cytometric assay were done to determine cell viability and cell apoptosis, respectively.

RESULTS

All concentrations of both agents reduced viability significantly in a dose- and time-dependent fashion (p < 0.004). Both compounds, either single or combined agents, induced apoptosis significantly, whereas the ratio of the apoptotic cells treated with combined agents was more significant than the single.

CONCLUSION

Our findings suggest that vaproic acid and vorinostat can significantly inhibit cell growth and induce apoptosis in colon cancer SW48 cells.

摘要

目的

组蛋白的乙酰化水平是组蛋白乙酰转移酶和组蛋白去乙酰化酶活性平衡的结果,这在染色质重塑和基因表达调控中起重要作用。诸如丙戊酸、伏立诺他等组蛋白去乙酰化酶抑制剂因其诱导癌细胞分化和凋亡的能力而受到关注。本研究旨在评估丙戊酸与伏立诺他相比以及联合使用时对人结肠癌SW48细胞生长抑制和凋亡诱导的影响。

材料与方法

接种结肠癌SW48细胞,并用不同剂量的丙戊酸和伏立诺他进行处理,分别采用MTT法和流式细胞术检测细胞活力和细胞凋亡情况。

结果

两种药物的所有浓度均以剂量和时间依赖性方式显著降低细胞活力(p<0.004)。两种化合物,无论是单一药物还是联合用药,均显著诱导凋亡,而联合用药处理的凋亡细胞比例比单一用药更显著。

结论

我们的研究结果表明,丙戊酸和伏立诺他可显著抑制结肠癌SW48细胞的生长并诱导其凋亡。

相似文献

1
Effect of valproic acid in comparison with vorinostat on cell growth inhibition and apoptosis induction in the human colon cancer SW48 cells in vitro.丙戊酸与伏立诺他相比对人结肠癌SW48细胞体外生长抑制和凋亡诱导的影响。
Exp Oncol. 2018 Jun;40(2):95-100.
2
The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.组蛋白脱乙酰酶抑制剂辛二酰苯胺异羟肟酸(伏立诺他)和丙戊酸可诱导人结肠癌细胞产生不可逆且不依赖多药耐药基因1(MDR1)的耐药性。
Int J Oncol. 2007 Sep;31(3):633-41.
3
DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.应用 DNA 微阵列技术分析组蛋白去乙酰化酶抑制剂伏立诺他和 LBH589 调控结肠癌细胞系差异表达基因的表达谱。
BMC Med Genomics. 2009 Nov 30;2:67. doi: 10.1186/1755-8794-2-67.
4
In Vitro Effect of the Histone Deacetylase Inhibitor Valproic Acid on Viability and Apoptosis of the PLC/PRF5 Human Hepatocellular Carcinoma Cell Line.组蛋白去乙酰化酶抑制剂丙戊酸对人肝癌PLC/PRF5细胞系活力及凋亡的体外作用
Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2507-2510. doi: 10.22034/APJCP.2018.19.9.2507.
5
Effect of valproic acid and zebularine on SOCS-1 and SOCS-3 gene expression in colon carcinoma SW48 cell line.丙戊酸和 zebularine 对结肠癌 SW48 细胞系 SOCS-1 和 SOCS-3 基因表达的影响。
Exp Oncol. 2020 Sep;42(3):183-187. doi: 10.32471/exp-oncology.2312-8852.vol-42-no-3.15113.
6
Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.伏立诺他是一种组蛋白去乙酰化酶(HDAC)抑制剂,可促进细胞周期停滞,并使利妥昔单抗和化疗耐药的淋巴瘤细胞对化疗药物重新敏感。
J Cancer Res Clin Oncol. 2016 Feb;142(2):379-87. doi: 10.1007/s00432-015-2026-y. Epub 2015 Aug 28.
7
Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.顺铂与两种组蛋白去乙酰化酶抑制剂在MCF7、T47D和MDA-MB-231人乳腺癌细胞系中的相互作用评估——等效线图分析
PLoS One. 2015 Nov 18;10(11):e0143013. doi: 10.1371/journal.pone.0143013. eCollection 2015.
8
Effect of valproic acid on the proliferation and apoptosis of the human melanoma G-361 cell line.丙戊酸对人黑色素瘤G - 361细胞系增殖和凋亡的影响。
Acta Pol Pharm. 2014 Nov-Dec;71(6):917-21.
9
Epigenetic modulation of gene expression of human leukemia cell lines - induction of cell death and senescence.人类白血病细胞系基因表达的表观遗传调控 - 诱导细胞死亡和衰老。
Neoplasma. 2011;58(1):35-44. doi: 10.4149/neo_2011_01_35.
10
Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.丙戊酸抑制组蛋白去乙酰化酶后LNCaP人前列腺癌细胞中的表达变化。
Int J Oncol. 2004 Jan;24(1):25-31.

引用本文的文献

1
Twist1 Regulates the Immune Checkpoint VISTA and Promotes the Proliferation, Migration and Progression of Pancreatic Cancer Cells.Twist1调控免疫检查点VISTA并促进胰腺癌细胞的增殖、迁移和进展。
J Cell Mol Med. 2025 May;29(9):e70586. doi: 10.1111/jcmm.70586.
2
Repurposing of nervous system drugs for cancer treatment: recent advances, challenges, and future perspectives.用于癌症治疗的神经系统药物的重新利用:最新进展、挑战及未来展望。
Discov Oncol. 2025 Mar 26;16(1):396. doi: 10.1007/s12672-025-02067-4.
3
Repurposing of neprilysin inhibitor 'sacubitrilat' as an anti-cancer drug by modulating epigenetic and apoptotic regulators.
将 Neprilysin 抑制剂“沙库巴曲”通过调节表观遗传和凋亡调节剂重新用于抗癌药物。
Sci Rep. 2023 Jun 19;13(1):9952. doi: 10.1038/s41598-023-36872-0.
4
Effect of Sodium Butyrate on p16INK4a, p14ARF, p15INK4b, Class I HDACs (HDACs 1, 2, 3) Class II HDACs (HDACs 4, 5, 6), Cell Growth Inhibition and Apoptosis Induction in Pancreatic Cancer AsPC-1 and Colon Cancer HCT-116 Cell Lines.丁酸钠对胰腺癌 AsPC-1 和结肠癌 HCT-116 细胞系中 p16INK4a、p14ARF、p15INK4b、I 类组蛋白去乙酰化酶(HDACs 1、2、3)、II 类组蛋白去乙酰化酶(HDACs 4、5、6)、细胞生长抑制和凋亡诱导的影响。
Asian Pac J Cancer Prev. 2022 Mar 1;23(3):795-802. doi: 10.31557/APJCP.2022.23.3.795.
5
Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer.三阴性乳腺癌精准医学实施中的药物重新定位与亚组发现
Cancers (Basel). 2021 Dec 14;13(24):6278. doi: 10.3390/cancers13246278.
6
Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer.丙戊酸对甲状腺癌模型中影响组蛋白去乙酰化酶的 miRNA 的影响。
Mol Biol Rep. 2021 Aug;48(8):6085-6091. doi: 10.1007/s11033-021-06616-2. Epub 2021 Aug 10.
7
The Effects of 5-Aza-2'-Deoxycytidine and Valproic Acid on Apoptosis Induction and Cell Growth Inhibition in Colon Cancer HT 29 Cell Line.5-氮杂-2'-脱氧胞苷和丙戊酸对结肠癌HT 29细胞系凋亡诱导及细胞生长抑制的影响
Int J Prev Med. 2021 Mar 29;12:33. doi: 10.4103/ijpvm.IJPVM_410_19. eCollection 2021.
8
Effect of vorinostat on INK4 family and HDACs 1, 2, and 3 in pancreatic cancer and hepatocellular carcinoma.伏立诺他对胰腺癌和肝癌中INK4家族以及组蛋白去乙酰化酶1、2和3的影响。
Res Pharm Sci. 2021 May 12;16(3):260-268. doi: 10.4103/1735-5362.314824. eCollection 2021 Jun.
9
New drugs are not enough‑drug repositioning in oncology: An update.新药研发还不够——肿瘤药物再定位:最新进展。
Int J Oncol. 2020 Mar;56(3):651-684. doi: 10.3892/ijo.2020.4966. Epub 2020 Jan 20.
10
Effect of 5-Aza-2'-Deoxycytidine in Comparison to Valproic Acid and Trichostatin A on Histone Deacetylase 1, DNA Methyltransferase 1, and CIP/KIP Family (p21, p27, and p57) Genes Expression, Cell Growth Inhibition, and Apoptosis Induction in Colon Cancer SW480 Cell Line.5-氮杂-2'-脱氧胞苷与丙戊酸和曲古抑菌素A相比对结肠癌SW480细胞系中组蛋白去乙酰化酶1、DNA甲基转移酶1和CIP/KIP家族(p21、p27和p57)基因表达、细胞生长抑制及凋亡诱导的影响
Adv Biomed Res. 2019 Aug 21;8:52. doi: 10.4103/abr.abr_91_19. eCollection 2019.